Product image of Levetiracetam Tillomed (Levetiracetam) supplied by GNH India

Levetiracetam Tillomed

Active Ingredient:
Levetiracetam
Origin:
EU

Levetiracetam Tillomed (Levetiracetam)

Levetiracetam, the active ingredient in Levetiracetam Tillomed, is an anticonvulsant presented as an intravenous solution for IV use. It is employed to treat partial and generalized seizure disorders in patients requiring parenteral therapy. It is indicated for patients with refractory epilepsy and is available for intravenous administration in acute care settings.

GNH India supplies Levetiracetam Tillomed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Tillomed Italia S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Levetiracetam is an anticonvulsant that acts on neuronal excitability to control seizure activity.

  • Partial seizures: reduces frequency and severity of focal onset seizures.
  • Generalized tonic‑clonic seizures: helps prevent convulsive episodes in patients with generalized epilepsy.
  • Myoclonic seizures: decreases occurrence of sudden muscle jerks associated with myoclonic epilepsy.
  • Adjunct therapy: used as add‑on treatment when seizures are not controlled by other antiepileptics.

How It Works

  • Levetiracetam binds to the synaptic vesicle protein SV2A, a key regulator of neurotransmitter release. This interaction modulates calcium‑dependent vesicle exocytosis, stabilizing neuronal membranes and reducing hyper‑synchronised firing. By decreasing the release of excitatory neurotransmitters, the drug lowers neuronal excitability and helps prevent the initiation and propagation of seizure activity. The precise downstream pathways remain under investigation, but the net effect is a dampening of abnormal electrical discharge across cortical networks.

Side Effects

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Fatigue: persistent tiredness or lack of energy.
  • Somnolence: increased sleepiness during the day.
  • Headache: mild to moderate cranial pain.
  • Irritability: mood changes including agitation.
  • Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Stevens‑Johnson syndrome: serious skin disorder with blistering.
  • Blood dyscrasias: neutropenia or thrombocytopenia.
  • Suicidal thoughts: emergence of depressive ideation.
  • Severe depression: marked mood disturbances.
  • Rash with mucosal involvement: potential toxic epidermal necrolysis.

Precautions & Warnings

When prescribing Levetiracetam, clinicians should consider several safety precautions to minimise risk.

  • Renal impairment: adjust dose based on creatinine clearance.
  • Hepatic impairment: monitor liver function tests.
  • Pregnancy: potential unknown risks; use only if benefit outweighs risk.
  • Concomitant CNS depressants: may enhance sedation.
  • Mood changes: observe for depression or suicidal ideation.
  • Store at below 25°C: keep in original packaging, protect from moisture and light.

Avoid Interactions

Levetiracetam can interact with other medicines, influencing its plasma levels or enhancing side‑effects.

Major Interactions (Avoid)

  • Carbamazepine: reduces levetiracetam concentrations.
  • Phenobarbital: decreases levetiracetam exposure.
  • Phenytoin: may lower levetiracetam levels.
  • Rifampin: induces metabolism, lowering efficacy.
  • Enzyme‑inducing antiepileptics: overall decrease drug exposure.

Moderate Interactions (Monitor Closely)

  • Alcohol: additive CNS depression.
  • Other antiepileptics: may require dose adjustments.
  • Oral contraceptives: possible reduced hormonal efficacy.
  • Sedatives or hypnotics: increased drowsiness.
  • Antidepressants: monitor for mood changes.

Frequently Asked Questions

Levetiracetam Tillomed is an intravenous antiepileptic medication indicated for the treatment of partial, generalized tonic‑clonic, and myoclonic seizures. It is used in patients who require rapid seizure control or cannot take oral formulations, such as those in intensive care or emergency settings.

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This binding reduces calcium‑dependent vesicle exocytosis, stabilising neuronal membranes and decreasing the likelihood of abnormal, synchronized electrical activity that leads to seizures.

The dose of Levetiracetam Tillomed is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal function, seizure type, and response to therapy. No fixed regimen is provided here; the prescriber sets the appropriate dosing schedule.

Safety data for Levetiracetam in pregnancy and lactation are limited, and the product carries an unknown pregnancy category. Use is generally reserved for situations where the potential benefit to the mother outweighs any possible risk to the fetus or infant. Consultation with a specialist is advised.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Levetiracetam Tillomed. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Levetiracetam offers a distinct mechanism by targeting SV2A, which differs from sodium‑channel blockers like carbamazepine or GABA‑enhancers such as phenobarbital. It has a relatively favorable drug‑interaction profile, minimal protein binding, and can be administered intravenously, making it useful for rapid seizure control and in patients with complex medication regimens.

Levetiracetam Tillomed should be stored at temperatures below 25 °C. Keep the vials in their original packaging, protect them from moisture and direct light, and avoid freezing. Follow any additional handling instructions provided with the product to maintain stability.

Levetiracetam Tillomed is given by intravenous infusion. The exact infusion rate and duration are determined by the treating physician, based on the clinical situation and patient characteristics. Administration should be performed by qualified healthcare personnel in a setting equipped for IV therapy.

Serious adverse reactions, although rare, include severe allergic responses such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias like neutropenia, and emergence of suicidal thoughts or severe depression. Prompt medical attention is required if any of these events occur.

Levetiracetam Tillomed is contraindicated in patients with known hypersensitivity to levetiracetam or any of the formulation components. Caution is also advised for individuals with severe renal impairment who have not had dose adjustments, and for pregnant or breastfeeding women unless the therapeutic benefit justifies potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Levetiracetam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT